Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

Combination therapy of active hexose correlated compound plus UFT significantly reduces the metastasis of rat mammary adenocarcinoma.

Matsushita K, Kuramitsu Y, Ohiro Y, Obara M, Kobayashi M, Li YQ, Hosokawa M.

Anticancer Drugs. 1998 Apr;9(4):343-50.

PMID:
9635925
2.

[Inhibitory effect of UFT on postoperative lung metastasis of mammary adenocarcinoma in SHR rats].

Komatsumoto M, Li S, Hamada J, Takeichi N, Hosokawa M, Okayasu T, Tanabe T, Kobayashi H.

Gan To Kagaku Ryoho. 1988 May;15(5):1739-45. Japanese.

PMID:
3130810
3.

[Timing of UFT administration combined with surgical operation in pulmonary metastasis of rat mammary carcinoma].

Li XB, Hamada J, Takeichi N, Hosokawa M, Kobayashi H.

Gan To Kagaku Ryoho. 1989 Jul;16(7):2381-5. Japanese.

PMID:
2502073
4.

Low-dose supplementation with active hexose correlated compound improves the immune response to acute influenza infection in C57BL/6 mice.

Nogusa S, Gerbino J, Ritz BW.

Nutr Res. 2009 Feb;29(2):139-43. doi: 10.1016/j.nutres.2009.01.005.

PMID:
19285605
5.

[Host defense mechanisms against tumor metastasis].

Takeichi N.

Gan To Kagaku Ryoho. 1985 Jun;12(6):1210-21. Japanese.

PMID:
4004288
6.
7.

Postsurgical oral administration of uracil and tegafur inhibits progression of micrometastasis of human breast cancer cells in nude mice.

Kurebayashi J, Nukatsuka M, Fujioka A, Saito H, Takeda S, Unemi N, Fukumori H, Kurosumi M, Sonoo H, Dickson RB.

Clin Cancer Res. 1997 May;3(5):653-9.

8.

Active hexose correlated compound enhances tumor surveillance through regulating both innate and adaptive immune responses.

Gao Y, Zhang D, Sun B, Fujii H, Kosuna K, Yin Z.

Cancer Immunol Immunother. 2006 Oct;55(10):1258-66. Epub 2005 Dec 16.

PMID:
16362410
9.
10.

Direct evidence for the role of LGL in the inhibition of experimental tumor metastases.

Barlozzari T, Leonhardt J, Wiltrout RH, Herberman RB, Reynolds CW.

J Immunol. 1985 Apr;134(4):2783-9.

PMID:
3871818
11.
12.
13.

Effects of the anticancer drug cocktail "UFT" on metastatic potentials of squamous cell carcinoma (O-1N) in a hamster model.

Naito Y, Kimura S, Yoshizawa M, Ohtake K, Nakajima T, Saku T.

Oral Oncol. 1998 Sep;34(5):326-31.

PMID:
9861336
14.

Alleviating effect of active hexose correlated compound (AHCC) for anticancer drug-induced side effects in non-tumor-bearing mice.

Shigama K, Nakaya A, Wakame K, Nishioka H, Fujii H.

J Exp Ther Oncol. 2009;8(1):43-51.

PMID:
19827270
15.

Effects of oral UFT combined with or without zoledronic acid on bone metastasis in the 4T1/luc mouse breast cancer.

Hiraga T, Ueda A, Tamura D, Hata K, Ikeda F, Williams PJ, Yoneda T.

Int J Cancer. 2003 Oct 10;106(6):973-9.

16.
17.

The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice.

Hirose A, Sato E, Fujii H, Sun B, Nishioka H, Aruoma OI.

Toxicol Appl Pharmacol. 2007 Jul 15;222(2):152-8. Epub 2007 Apr 20.

PMID:
17555784
18.

[Experimental studies on the combined effect of radiation and UFT: 2. fractionated treatments combining UFT and X ray radiation].

Yamakawa M, Niibe H, Honjo J, Hasegawa M, Kazumoto T, Akimoto T, Huruta M, Yonome I, Kawaharada U.

Gan To Kagaku Ryoho. 1990 Jun;17(6):1173-9. Japanese.

PMID:
2112371
19.
20.

On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing.

Man S, Munoz R, Kerbel RS.

Cancer Metastasis Rev. 2007 Dec;26(3-4):737-47. Review.

PMID:
17846863

Supplemental Content

Support Center